187 related articles for article (PubMed ID: 9664114)
1. Inhibition by oral N-acetylcysteine of doxorubicin-induced clastogenicity and alopecia, and prevention of primary tumors and lung micrometastases in mice.
D'Agostini F; Bagnasco M; Giunciuglio D; Albini A; De Flora S
Int J Oncol; 1998 Aug; 13(2):217-24. PubMed ID: 9664114
[TBL] [Abstract][Full Text] [Related]
2. Synergism between N-acetylcysteine and doxorubicin in the prevention of tumorigenicity and metastasis in murine models.
De Flora S; D'Agostini F; Masiello L; Giunciuglio D; Albini A
Int J Cancer; 1996 Sep; 67(6):842-8. PubMed ID: 8824557
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of invasion, gelatinase activity, tumor take and metastasis of malignant cells by N-acetylcysteine.
Albini A; D'Agostini F; Giunciuglio D; Paglieri I; Balansky R; De Flora S
Int J Cancer; 1995 Mar; 61(1):121-9. PubMed ID: 7705924
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of N-acetylcysteine, caffeic acid and vitamin E on doxorubicin hepatotoxicity.
Gokcimen A; Cim A; Tola HT; Bayram D; Kocak A; Ozgüner F; Ayata A
Hum Exp Toxicol; 2007 Jun; 26(6):519-25. PubMed ID: 17698947
[TBL] [Abstract][Full Text] [Related]
5. Combination of anti-cell adhesive synthetic Arg-Gly-Asp-Ser analogue and anticancer drug doxorubicin heightens their original antimetastatic activities.
Komazawa H; Fujii H; Kojima M; Mori H; Ono M; Itoh I; Azuma I; Saiki I
Oncol Res; 1995; 7(7-8):341-51. PubMed ID: 8747597
[TBL] [Abstract][Full Text] [Related]
6. Modulation of doxorubicin-induced genotoxicity by squalene in Balb/c mice.
Narayan BH; Tatewaki N; Giridharan VV; Nishida H; Konishi T
Food Funct; 2010 Nov; 1(2):174-9. PubMed ID: 21776469
[TBL] [Abstract][Full Text] [Related]
7. Chemoprevention by N-acetylcysteine of urethane-induced clastogenicity and lung tumors in mice.
Balansky RM; De Flora S
Int J Cancer; 1998 Jul; 77(2):302-5. PubMed ID: 9650568
[TBL] [Abstract][Full Text] [Related]
8. Induction, persistence and modulation of cytogenetic alterations in cells of smoke-exposed mice.
Balansky RM; D' Agostini F; De Flora S
Carcinogenesis; 1999 Aug; 20(8):1491-7. PubMed ID: 10426797
[TBL] [Abstract][Full Text] [Related]
9. Antimetastatic effect by anti-adhesion therapy with cell-adhesive peptide of fibronectin in combination with anticancer drugs.
Saiki I; Yoneda J; Kobayashi H; Igarashi Y; Komazawa H; Ishizaki Y; Kato I; Azuma I
Jpn J Cancer Res; 1993 Mar; 84(3):326-35. PubMed ID: 8486531
[TBL] [Abstract][Full Text] [Related]
10. N-acetylcysteine prevents doxorubucine-induced cardiotoxicity in rats.
Arica V; Demir İH; Tutanc M; Basarslan F; Arica S; Karcoıglu M; Öztürk H; Nacar A
Hum Exp Toxicol; 2013 Jun; 32(6):655-61. PubMed ID: 23424206
[TBL] [Abstract][Full Text] [Related]
11. Antitumor, nephrotoxic and clastogenic effect of cis-DDP with DDTC or NAC.
Konstantinov S; Topashka-Ancheva M; Karaivanova M; Zoneva G; Galova I
Neoplasma; 1994; 41(5):253-8. PubMed ID: 7854494
[TBL] [Abstract][Full Text] [Related]
12. N-acetylcysteine modulates doxorubicin-induced oxidative stress and antioxidant vitamin concentrations in liver of rats.
Koçkar MC; Nazıroğlu M; Celik O; Tola HT; Bayram D; Koyu A
Cell Biochem Funct; 2010 Dec; 28(8):673-7. PubMed ID: 21104935
[TBL] [Abstract][Full Text] [Related]
13. Chemoprevention of smoke-induced alopecia in mice by oral administration of L-cystine and vitamin B6.
D'Agostini F; Fiallo P; Pennisi TM; De Flora S
J Dermatol Sci; 2007 Jun; 46(3):189-98. PubMed ID: 17374475
[TBL] [Abstract][Full Text] [Related]
14. Assessing the therapeutic efficacy of VEGFR-1-targeted polymer drug conjugates in mouse tumor models.
Shamay Y; Golan M; Tyomkin D; David A
J Control Release; 2016 May; 229():192-199. PubMed ID: 27001892
[TBL] [Abstract][Full Text] [Related]
15. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.
Pinniger GJ; Terrill JR; Assan EB; Grounds MD; Arthur PG
J Physiol; 2017 Dec; 595(23):7093-7107. PubMed ID: 28887840
[TBL] [Abstract][Full Text] [Related]
16. Acute doxorubicin nephrotoxicity in rats with malignant neoplasm can be successfully treated with fullerenol C60(OH)24 via suppression of oxidative stress.
Injac R; Boskovic M; Perse M; Koprivec-Furlan E; Cerar A; Djordjevic A; Strukelj B
Pharmacol Rep; 2008; 60(5):742-9. PubMed ID: 19066422
[TBL] [Abstract][Full Text] [Related]
17. Concomitant low-dose doxorubicin treatment and exercise.
Sturgeon K; Schadler K; Muthukumaran G; Ding D; Bajulaiye A; Thomas NJ; Ferrari V; Ryeom S; Libonati JR
Am J Physiol Regul Integr Comp Physiol; 2014 Sep; 307(6):R685-92. PubMed ID: 25009215
[TBL] [Abstract][Full Text] [Related]
18. A low-molecular-weight heparin-coated doxorubicin-liposome for the prevention of melanoma metastasis.
Chen Y; Peng J; Han M; Omar M; Hu D; Ke X; Lu N
J Drug Target; 2015 May; 23(4):335-46. PubMed ID: 25541466
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic efficacy of metronomic chemotherapy with cyclophosphamide and doxorubicin on murine mammary adenocarcinomas.
Mainetti LE; Rico MJ; Fernández-Zenobi MV; Perroud HA; Roggero EA; Rozados VR; Scharovsky OG
Ann Oncol; 2013 Sep; 24(9):2310-6. PubMed ID: 23666914
[TBL] [Abstract][Full Text] [Related]
20. Modulation of doxorubicin-induced genotoxicity by Aegle marmelos in mouse bone marrow: a micronucleus study.
Venkatesh P; Shantala B; Jagetia GC; Rao KK; Baliga MS
Integr Cancer Ther; 2007 Mar; 6(1):42-53. PubMed ID: 17351026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
